Cargando…

Alternatively spliced VEGF receptor-2 is an essential endogenous inhibitor of lymphatic vessels

Disruption of the precise balance of positive and negative molecular regulators of blood and lymphatic vessels can lead to myriad diseases that affect one in four people worldwide. Although dozens of natural inhibitors of hemangiogenesis have been identified, an endogenous selective inhibitor of lym...

Descripción completa

Detalles Bibliográficos
Autores principales: Albuquerque, Romulo J.C., Hayashi, Takahiko, Cho, Won Gil, Kleinman, Mark E., Dridi, Sami, Takeda, Atsunobu, Baffi, Judit Z., Yamada, Kiyoshi, Kaneko, Hiroki, Green, Martha G., Chappell, Joe, Wilting, Jörg, Weich, Herbert A., Yamagami, Satoru, Amano, Shiro, Mizuki, Nobuhisa, Alexander, Jonathan S., Peterson, Martha L., Brekken, Rolf A., Hirashima, Masanori, Capoor, Seema, Usui, Tomohiko, Ambati, Balamurali K., Ambati, Jayakrishna
Formato: Texto
Lenguaje:English
Publicado: 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2882165/
https://www.ncbi.nlm.nih.gov/pubmed/19668192
http://dx.doi.org/10.1038/nm.2018
Descripción
Sumario:Disruption of the precise balance of positive and negative molecular regulators of blood and lymphatic vessels can lead to myriad diseases that affect one in four people worldwide. Although dozens of natural inhibitors of hemangiogenesis have been identified, an endogenous selective inhibitor of lymphatic vessels has not yet been described. We report the existence of a secreted, splice variant of vascular endothelial growth factor receptor-2 (sVegfr-2) that inhibits developmental and reparative lymphangiogenesis by blocking Vegf-c. Tissue-specific loss of sVegfr-2 in mice induced, at birth, spontaneous lymphatic invasion of the normally alymphatic cornea and hyperplasia of skin lymphatics without accompanying changes in blood vasculature. sVegfr-2 inhibited lymphangiogenesis but not hemangiogenesis induced by corneal suture injury or transplantation, enhanced corneal allograft survival, and suppressed lymphangioma cellular proliferation. Naturally occurring sVegfr-2 is a molecular uncoupler of blood and lymphatic vessels whose modulation might have a therapeutic role in lymphatic vascular malformations, transplantation, and potentially in tumor lymphangiogenesis and lymphedema.